Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PVLA

Palvella Therapeutics Inc

151.04

Jul 09 • 04:00PM ET +5.85 (4.03%)

Healthcare Biotechnology USA Mid NASD

Peers: KYMR MANE ORKA RYTM KRYS NUVL BMRN INCY AXSM NBIX

| Held by: XBI VTI IWM IWO VXF VTWO VHT VFMO LFSC SBIO

Scroll to Statements

Index	RUT
Market Cap	2.17B
Enterprise Value	1.92B
Income	-49.30M
Sales	0.00M
Book/sh	16.23
Cash/sh	18.26
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	29
IPO	Jan 02, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	9.31
P/C	8.27
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	28.88
Current Ratio	28.88
Debt/Eq	0.09
LT Debt/Eq	0.09
Option/Short	Yes / Yes

EPS (ttm)	-4.17
EPS next Y	-6.43
EPS next Q	-1.16
EPS this Y	-48.88%
EPS next Y	-16.45%
EPS next 5Y	12.81%
EPS past 3/5Y	53.08% 41.62%
Sales past 3/5Y	- -
EPS Y/Y TTM	66.94%
Sales Y/Y TTM	-
EPS Q/Q	-62.12%
Sales Q/Q	-
Earnings	May 07 BMO
EPS/Sales Surpr.	-28.34% -

Insider Own	29.40%
Insider Trans	-0.45%
Inst Own	83.76%
Inst Trans	33.22%
ROA	-28.73%
ROE	-34.25%
ROIC	-19.52%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	16.34%
SMA50	23.46%
SMA200	46.42%
Trades

Shs Outstand	14.31M
Shs Float	10.13M
Short Float	20.50%
Short Ratio	8.02
Short Interest	2.08M
52W High	161.38 -6.41%
52W Low	24.80 509.16%
Volatility	6.45% 6.70%
ATR (14)	9.13
RSI (14)	63.99
Beta	-0.17
Rel Volume	1.06
Avg Volume	258.84K
Volume	274,681

Perf Week	9.24%
Perf Month	43.51%
Perf Quarter	22.63%
Perf Half Y	67.02%
Perf YTD	44.30%
Perf Year	485.43%
Perf 3Y	1030.54%
Perf 5Y	-48.83%
Perf 10Y	14.42%
Recom	1.00
Target Price	229.00
Prev Close	145.19
Price	151.04
Change	4.03%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)